Share-based Payment Arrangement, Expense of Harmony Biosciences Holdings, Inc. from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Harmony Biosciences Holdings, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2019 to 31 Dec 2025.
  • Harmony Biosciences Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $10,292,000, a 4.4% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $44,960,000, a 5.3% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $44,960,000, a 5.3% increase from 2024.
  • Harmony Biosciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $42,701,000, a 37% increase from 2023.
  • Harmony Biosciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $31,206,000, a 16% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Harmony Biosciences Holdings, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $44,960,000 $10,292,000 +$436,000 +4.4% 01 Oct 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $44,524,000 $10,824,000 -$624,000 -5.5% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $45,148,000 $11,394,000 +$431,000 +3.9% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $44,717,000 $12,450,000 +$2,016,000 +19% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $42,701,000 $9,856,000 +$961,000 +11% 01 Oct 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $41,740,000 $11,448,000 +$3,491,000 +44% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $38,249,000 $10,963,000 +$3,170,000 +41% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $35,079,000 $10,434,000 +$3,873,000 +59% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $31,206,000 $8,895,000 +$1,224,000 +16% 01 Oct 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
Q3 2023 $29,982,000 $7,957,000 +$990,000 +14% 01 Jul 2023 30 Sep 2023 10-Q 29 Oct 2024 2024 Q3
Q2 2023 $28,992,000 $7,793,000 +$422,000 +5.7% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $28,570,000 $6,561,000 +$1,665,000 +34% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024 2024 Q1
Q4 2022 $26,905,000 $7,671,000 +$3,288,000 +75% 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
Q3 2022 $23,617,000 $6,967,000 +$2,303,000 +49% 01 Jul 2022 30 Sep 2022 10-Q 31 Oct 2023 2023 Q3
Q2 2022 $21,314,000 $7,371,000 +$3,564,000 +94% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q2
Q1 2022 $17,750,000 $4,896,000 +$1,645,000 +51% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q4 2021 $16,105,000 $4,383,000 +$1,459,000 +50% 01 Oct 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
Q3 2021 $14,646,000 $4,664,000 +$3,334,000 +251% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022 2022 Q3
Q2 2021 $11,312,000 $3,807,000 +$3,346,000 +726% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022 2022 Q2
Q1 2021 $7,966,000 $3,251,000 +$2,776,000 +584% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q4 2020 $5,190,000 $2,924,000 01 Oct 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
Q3 2020 $1,330,000 +$923,000 +227% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $461,000 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q1 2020 $475,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 $407,000 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3

Harmony Biosciences Holdings, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $44,960,000 +$2,259,000 +5.3% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $42,701,000 +$11,495,000 +37% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $31,206,000 +$4,301,000 +16% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $26,905,000 +$10,800,000 +67% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 $16,105,000 +$10,915,000 +210% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $5,190,000 -$4,719,000 -48% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $9,909,000 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.